UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 148/2024

May 13, 2024·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Action number: ACT 16120/2024

Follow
Case details
Status
Case Closed (No infringement)
Action
Infringement
Category
Main infringement action
Parties
Claimants
Representatives
Respondents
Representatives
Division
Munich LD
Judges
Technology
  • Chemistry
    Pharmaceuticals
Language
English
First decided
Sep 15, 2025
Last decision
Dec 12, 2025
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
Munich LDLockedLocked
Judge Matthias ZigannLockedLocked
Judge Alima ZanaLockedLocked
Judge Tobias PichlmaierLockedLocked
Judge Carola WagnerLockedLocked

At the UPC: Sanofi Group (33 cases)·Zentiva Group (15 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 9 other proceedings

UPC CoA 24/2026·UPC CoA 27/2026·UPC CFI 98/2026·UPC CFI 99/2026·UPC CFI 503/2024 and 4 more

10 other defendants litigating the same or a related patent

UPC CoA 22/2026·UPC CoA 23/2026·UPC CoA 25/2026·UPC CoA 26/2026·UPC CFI 496/2024 and 5 more

Start a free trial to see how each one ended.

More cases: Munich LD·2024

Decisions
  • 2025-12-12
    Infringement ActionPublic

    Summary: The Munich Local Division issued a rectification order under Rule 353 RoP correcting factual errors in a prior decision in the Sanofi v. Stada/Dr Reddy/Zentiva proceedings, including corrections regarding marketing authorisation holders and expert witness attribution.

    Show the legal issues (1)
    • Rectification of decisions Rule 353 RoP
  • 2025-12-12
    Infringement ActionPublic

    Summary: The Munich Local Division found patent EP 2 493 466 (relating to cabazitaxel pharmaceutical formulations) invalid for lack of inventive step in infringement proceedings brought by Sanofi against STADA, Dr. Reddy's and Zentiva entities, dismissing the infringement claims.

    Show the legal issues (4)
    • Inventive step (cabazitaxel formulation)
    • Infringement
    • Pharmaceutical patent
    • Counterclaim for revocation
  • 2025-09-15
    Infringement ActionPublic

    Summary: Munich Local Division order (judge-rapporteur Zigann) following the second interim conference in consolidated infringement proceedings by Sanofi entities against Zentiva, STADA, Dr. Reddy's and Accord Healthcare groups concerning EP 2 493 466 (insulin glargine). The order confirms the oral hearing dates (14-17 October 2025), orders all four counterclaims to be heard together with separate handling of each infringement action, and gives organisational directions for the hearing.

    Show the legal issues (3)
    • Oral hearing scheduling (R. 105.5 RoP)
    • Coordination of joint counterclaims for revocation with multiple infringement actions
    • Insulin glargine / pharmaceutical patent
Documents
Document titleDatePublic
Note2026-05-19Not public
Receipt2026-04-22Not public
Cover sheet2026-04-22Not public
Application document Defendant2026-04-22Not public
Receipt2026-04-22Not public
Cover sheet2026-04-22Not public
Application document Defendant2026-04-22Not public
Note2026-04-15Not public
Note2026-03-11Not public
Decision2026-02-13Not public
Final Order2026-02-13Public
Note2026-02-06Not public
Receipt2026-02-04Not public
Cover sheet2026-02-04Not public
Application document Claimant2026-02-04Not public
Receipt2026-01-12Not public
Cover sheet2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Exhibit document Respondent2026-01-12Not public
Application document Respondent2026-01-12Not public
Order2026-01-09Not public
Order2026-01-09Not public
Case closed2025-12-16Not public
Decision2025-12-16Public
Decision2025-12-12Not public
Decision2025-12-12Not public
Other Documents2025-11-19Not public
Cover sheet2025-11-03Not public
Application document Claimant2025-11-03Not public
Receipt2025-11-03Not public
Headnote-and-Keywords2025-09-15Not public
Interim-Procedure-Closure2025-09-15Not public
Summon-Oral-Hearing2025-09-15Not public
summons party expert witnesses2025-09-15Not public
R 105.5 - 2nd interim conference - 12 Sep. 20252025-09-15Not public
Hearing-Dates2025-09-15Not public
R 105.5 - 2nd interim conference - 12 Sep. 20252025-09-15Not public
oral hearing reference - IC2025-09-15Not public
oral hearing reference - IC2025-09-15Not public
Fix-Interim-Conference-Date2025-09-10Not public
Interim-Conference-Decision2025-09-10Not public
Written-Procedure-Closure2025-09-10Not public
Receipt2025-09-02Not public
Receipt2025-09-02Not public
Application2025-09-01Not public
2025 09 01 Sanofi vs. Zentiva_ZENTIVA_Application R. 176 RoP_R. 9 RoP_PDFA2025-09-01Not public
DFMP_119_Copy_of_the EPO_TBA_communication_on_issuance_of_written_decision_of_18_August_20252025-09-01Not public
DFMP_118_Overview_Document_evidencing_the_relevant_facts_as_well_as_reference_to_the_most_important_citation_therein2025-09-01Not public
Receipt2025-08-11Not public
Exhibit_DFMP_D117_Expert_Opinion_of_Prof_Mueller2025-08-08Not public
2025_08_08_Sanovi_vs._Zentiva_ZENTIVA_Counterclaim_for_revocation_Rule_9_brief_experts2025-08-08Not public
Exhibit_DFMP_D116_PM_5.1_Declaration_by_Dr._Samuel_Denmeade2025-08-08Not public
Anonymized decision bis - 22248-2025 - 17.07.20252025-08-07Not public
Anonymizd decision 22248-2025 - 17.07.20252025-08-07Not public
Headnote-and-Keywords2025-07-17Not public
Headnote-and-Keywords2025-07-17Not public
R 105.5 RoP2025-07-17Public
R 105.5 RoP2025-07-17Not public
R 105.5 RoP2025-07-17Public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-change-of-a-representative2025-07-10Not public
Acknowledgement-of-lodging2025-07-08Not public
2025 07 08 Sanovi vs. Zentiva_ZENTIVA_Rejoinder Infringement_Reply Counterclaim_signed2025-07-08Not public
Exhibit_DFMP_D115_signed2025-07-08Not public
Exhibit_TW_D_15_signed2025-07-08Not public
Exhibit_DFMP_D114_signed2025-07-08Not public
Exhibit_TW_D_17_signed2025-07-08Not public
Exhibit_TW_D_14_signed2025-07-08Not public
Exhibit_TW_D_16_signed2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
Exhibit_DFMP_D114_signed2025-07-08Not public
Exhibit_TW_D_14_signed2025-07-08Not public
2025 07 08 Sanovi vs. Zentiva_ZENTIVA_Rejoinder Infringement_Reply Counterclaim_signed2025-07-08Not public
Exhibit_TW_D_16_signed2025-07-08Not public
Exhibit_DFMP_D115_signed2025-07-08Not public
Exhibit_TW_D_17_signed2025-07-08Not public
Exhibit_TW_D_15_signed2025-07-08Not public
Acknowledgement-of-lodging2025-07-08Not public
Exhibit_TW_D_15_signed2025-07-08Not public
Exhibit_TW_D_16_signed2025-07-08Not public
Exhibit_DFMP_D114_signed2025-07-08Not public
Exhibit_TW_D_17_signed2025-07-08Not public
2025 07 08 Sanovi vs. Zentiva_ZENTIVA_Rejoinder Infringement_Reply Counterclaim_signed2025-07-08Not public
Exhibit_TW_D_14_signed2025-07-08Not public
Exhibit_DFMP_D115_signed2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Application-RoP293-Receipt2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Formal-checks_Notification-of-positive-outcome2025-07-08Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application-RoP2932025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Application2025-06-27Not public
Headnote-and-Keywords2025-06-27Not public
Outcome of the Order2025-06-27Not public
R 333 final signed2025-06-27Public
Comments2025-06-09Not public
R.333.2.2 - oberservations2025-06-04Not public
Acknowledgement-of-lodging2025-06-03Not public
Exhibit TW D13_signed2025-05-22Not public
Sanofi_v_Zentiva_ZENTIVA_Request for panel review2025-05-22Not public
Comments2025-05-15Not public
Preliminary_Objection_DecisionOutcome2025-05-14Not public
R 20.22025-05-14Not public
R 20.22025-05-14Public
hearing reference2025-05-14Not public
hearing reference2025-05-14Not public
confidentialty - oberservations2025-05-11Not public
order 8 May 2025 tailored2025-05-11Not public
order 8 May 2025 tailored2025-05-11Not public
Headnote-and-Keywords2025-05-09Not public
Outcome of the Order2025-05-08Not public
final order2025-05-08Not public
final order2025-05-08Public
Outcome of the Order2025-05-08Not public
final order2025-05-08Public
final order2025-05-08Not public
final order2025-05-08Public
final order2025-05-08Not public
Exhibit TW D 11_signed2025-04-09Not public
Exhibit TW D 12B_373-740_signed2025-04-09Not public
Exhibit TW D 10_signed2025-04-09Not public
2025 04 09 Sanofi_v_Zentiva_ZENTIVA_Reply to Sanofi Comments No 2 R. 105_signed2025-04-09Not public
Exhibit TW D 9_signed2025-04-09Not public
Exhibit TW D 12A_1-372_signed2025-04-09Not public
Outcome of the Order2025-03-21Not public
262 A - final2025-03-21Public
262 A - final2025-03-21Public
Comments No. 2 Rule 105(5) RoP (Zentiva - redacted)2025-03-20Not public
Exhibit No. F.052025-03-20Not public
Exhibit No. B.01.1.c2025-03-20Not public
Exhibit No. F.032025-03-20Not public
Exhibit No. F.042025-03-20Not public
Comments No. 2 Rule 105(5) RoP (Zentiva - unredacted)2025-03-20Not public
Exhibit No. F.062025-03-20Not public
Exhibit No. B.01.1.2.b2025-03-20Not public
Comments No. 2 Rule 105(5) RoP (Zentiva - unredacted)2025-03-20Not public
comments2025-02-27Not public
Receipt2025-02-13Not public
2025 02 12 Sanofi vs. Zentiva_ZENTIVA_Comment on Order ORD_3586-2025_Application under R. 263 RoP(40963292.1)_sig2025-02-12Not public
2025 02 12 Sanofi vs. Zentiva_ZENTIVA_Comment on Order ORD_3586-2025_Application under R. 263 RoP(40963292.1)_sig2025-02-12Not public
Comments 263 RoP2025-01-29Not public
Final Order R 105.5 anonymized2025-01-27Not public
R 105.5 - 15 Jan. 20252025-01-22Public
R 105.5 - 15 Jan. 20252025-01-22Not public
Template-Order2025-01-22Not public
Exhibit No. D.04 - New redacted version2025-01-17Not public
Outcome of the Order2025-01-17Not public
R 305 second - final2025-01-17Public
Hearing Reference2025-01-16Not public
Hearing Reference2025-01-16Not public
App_57840/2024 UPC_CFI_148/2024 - 262A - anonymized2025-01-15Not public
R 262 A - final2025-01-14Public
R 262 A - final2025-01-14Not public
Hearing-Dates2025-01-13Not public
R 305 second- oral comments2025-01-13Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Written Comments2025-01-10Not public
Receipt2025-01-09Not public
Application2025-01-09Not public
Exhibit No. A.02.22025-01-09Not public
Hearing-Dates2025-01-09Not public
R 19 - oral argument hearing2025-01-09Not public
R 305-310 final2025-01-07Public
R 262 A - comments2025-01-03Not public
Outcome of the Order2024-12-19Not public
extension request2024-12-19Public
Receipt2024-12-13Not public
Receipt2024-12-13Not public
Reply and Defence2024-12-13Not public
2024_12_10_Sanofi_vs._Zentiva_ZENTIVA_Application_extension_of_deadline_RoP_9_334_3362024-12-10Not public
R 37.2 final signed2024-11-12Public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.262A RoP_sig2024-11-12Not public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.262A RoP_sig2024-11-12Not public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.262A RoP_sig2024-11-12Not public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.305 RoP_sig2024-11-12Not public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.305 RoP_sig2024-11-12Not public
2024 11 12 Sanofi vs. Zentiva_ZENTIVA_Comment on R.305 RoP_sig2024-11-12Not public
Comment on application RoP 262A2024-11-05Not public
Outcome of the Order2024-11-05Not public
Comment Application RoP 3052024-11-05Public
Receipt2024-11-04Not public
Application2024-11-01Not public
Exhibit No. D.04 (REDACTED)2024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Reply and Defence2024-11-01Not public
Acknowledgement-of-lodging2024-11-01Not public
Exhibit No. B.04.42024-11-01Not public
Exhibit No. B.222024-11-01Not public
Exhibit No. B.062024-11-01Not public
Exhibit No. B.04.72024-11-01Not public
Exhibit No. B.04.82024-11-01Not public
Exhibit No. B.122024-11-01Not public
Exhibit No. B.22.12024-11-01Not public
Exhibit No. D.01.4 (2)2024-11-01Not public
Exhibit No. B.182024-11-01Not public
Exhibit No. B.17.12024-11-01Not public
Exhibit No. B.25 (6)2024-11-01Not public
Exhibit No. D.01.4 (1)2024-11-01Not public
Exhibit No. B.202024-11-01Not public
Exhibit No. G.042024-11-01Not public
Exhibit No. B.07.62024-11-01Not public
Exhibit No. G.072024-11-01Not public
Exhibit No. B.07.42024-11-01Not public
Exhibit No. B.04.52024-11-01Not public
Exhibit No. B.132024-11-01Not public
Exhibit No. B.09.12024-11-01Not public
Exhibit No. B.032024-11-01Not public
Exhibit No. B.16.12024-11-01Not public
Exhibit No. D.01.4 (3)2024-11-01Not public
Exhibit No. B.29 (1)2024-11-01Not public
Exhibit No. B.04.12024-11-01Not public
Exhibit No. B.04.22024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Exhibit No. B.112024-11-01Not public
Exhibit No. F.01.1 (1)2024-11-01Not public
Reply and Defence2024-11-01Not public
Exhibit No. 0.42024-11-01Not public
Exhibit No. B.192024-11-01Not public
Exhibit No. B.07.52024-11-01Not public
Exhibit No. D.03.32024-11-01Not public
Exhibit No. B.212024-11-01Not public
Exhibit No. B.272024-11-01Not public
Exhibit No. B.25 (3)2024-11-01Not public
Exhibit No. B.25 (2)2024-11-01Not public
Exhibit No. B.25 (5)2024-11-01Not public
Exhibit No. B.162024-11-01Not public
Exhibit No. G.012024-11-01Not public
Exhibit No. B.102024-11-01Not public
Exhibit No. B.17.22024-11-01Not public
Exhibit No. B.262024-11-01Not public
Exhibit No. B.05.12024-11-01Not public
Exhibit No. B.04.92024-11-01Not public
Exhibit No. B.22.22024-11-01Not public
Exhibit No. B.282024-11-01Not public
Exhibit No. B.07.22024-11-01Not public
Exhibit No. F.01.1 (2)2024-11-01Not public
Exhibit No. B.25 (4)2024-11-01Not public
Exhibit No. G.062024-11-01Not public
Exhibit No. B.04.32024-11-01Not public
Exhibit No. B.152024-11-01Not public
Exhibit No. B.25 (1)2024-11-01Not public
Exhibit No. B.082024-11-01Not public
Exhibit No. D.04 (UNREDACTED)2024-11-01Not public
Exhibit No. D.03.22024-11-01Not public
Exhibit No. B.172024-11-01Not public
Exhibit No. G.022024-11-01Not public
Exhibit No. B.242024-11-01Not public
Exhibit No. B.142024-11-01Not public
Exhibit No. B.01.1b2024-11-01Not public
Exhibit No. G.052024-11-01Not public
Exhibit No. F.01.1 (3)2024-11-01Not public
Exhibit No. B.07.12024-11-01Not public
Exhibit No. B.29 (2)2024-11-01Not public
Exhibit No. F.012024-11-01Not public
Exhibit No. B.092024-11-01Not public
Exhibit No. B.22.32024-11-01Not public
Exhibit No. B.07.32024-11-01Not public
Exhibit No. A.022024-11-01Not public
Exhibit No. D.01.32024-11-01Not public
Exhibit No. G.032024-11-01Not public
Exhibit No. B.052024-11-01Not public
Exhibit No. B.04.62024-11-01Not public
Exhibit No. F.022024-11-01Not public
Exhibit No. A.02.12024-10-23Not public
Exhibit No. A.02.12024-10-23Not public
Application2024-10-23Not public
2024 10 11 Sanofi vs. Zentiva Comment on Procedural Order of 1 October 2024 on bifurcation(40172664.1)2024-10-11Not public
2024 10 11 Sanofi vs. Zentiva Comment on Procedural Order of 1 October 2024 on bifurcation(40172664.1)2024-10-11Not public
2024 10 11 Sanofi vs. Zentiva Comment on Procedural Order of 1 October 2024 on bifurcation(40172664.1)2024-10-11Not public
2024 10 11 Sanofi vs. Zentiva Comment on Response to Preliminary Objection of 14. July 2024(40168894.1)2024-10-11Not public
2024 10 11 Sanofi vs. Zentiva Comment on Response to Preliminary Objection of 14. July 2024(40168894.1)2024-10-11Not public
2024 10 11 Sanofi vs. Zentiva Comment on Response to Preliminary Objection of 14. July 2024(40168894.1)2024-10-11Not public
Comments on bifurcation2024-10-10Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
Comments on bifurcation2024-10-07Not public
R 37.2 - comments2024-10-01Not public
R 19 - comments2024-10-01Not public
Hearing-Dates2024-09-16Not public
scheduling - final2024-09-16Public
Panel-Appointment2024-09-16Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
Comments2024-09-13Not public
2024 09 13 Sanofi vs. Zentiva Comment on Preliminary Order of 10_09_20242024-09-13Not public
2024 09 13 Sanofi vs. Zentiva Comment on Preliminary Order of 10_09_20242024-09-13Not public
2024 09 13 Sanofi vs. Zentiva Comment on Preliminary Order of 10_09_20242024-09-13Not public
Comments2024-09-13Not public
scheduling - comments2024-09-10Not public
Hearing-Dates2024-09-10Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Formal-checks_Notification-of-positive-outcome2024-09-03Not public
Acknowledgement-of-lodging2024-09-02Not public
DFMP D26 - Attard et al.2024-09-02Not public
DFMP D35 - Leaflet Aventis Oncology 20032024-09-02Not public
DFMP D1 - Sanofi-Aventis - XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone2024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
TW D 3 - Report EU Commission2024-09-02Not public
DFMP D72 - Scher et al.2024-09-02Not public
DFMP D102 - Tannock_Clin. Oncol. 19892024-09-02Not public
DFMP D9 - Galletti et al.2024-09-02Not public
DFMP D110 - Consolidated List of documents EPO2024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
DFMP D37 - Winquist et al.2024-09-02Not public
DFMP 1 - Confirmation of payment of court fees2024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D104 - Tannock_Clin. Oncol. 19962024-09-02Not public
DFMP P7 - Priority document US 61_3899692024-09-02Not public
DFMP D2 - National Horizon Scanning Centre2024-09-02Not public
DFMP D3b - Further blog post by Dr. Mirtsching July 6 20072024-09-02Not public
DFMP D90 - Goetz et al.2024-09-02Not public
DFMP D103 - Fossa. et al.2024-09-02Not public
DFMP P5 - Priority document US 61_3699292024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D111 - INN Publication 20082024-09-02Not public
DFMP P1 - Priority document US 61_2561602024-09-02Not public
2024 09 02 Sanofi vs. Zentiva Statement of Defence and Counterclaim for Revoc2024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP D112 - Excerpt from the online National Cancer Institute_s Drug Dictionary re. cabazitaxel2024-09-02Not public
DFMP D14 - FDA label for docetaxel (Taxotere) 20072024-09-02Not public
DFMP D18 - EMA Guideline on the Evaluation of Anticancer Medicinal Products in Man 20062024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D29 - Tannock et al.2024-09-02Not public
DFMP P2 - Priority document US 61_2939032024-09-02Not public
DFMP D7 - Beardsley et al.2024-09-02Not public
DFMP D109 - Albarqouni2024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D108 - Barraclough and Davis2024-09-02Not public
DFMP D3a - Blog post by Dr. Barry Mirtsching 12 October 20072024-09-02Not public
DFMP D15 - de Bono et al.2024-09-02Not public
DFMP D10 - Sanofi-Aventis Press Release_ 21 December 20092024-09-02Not public
DFMP D4 - Mita et al.2024-09-02Not public
DFMP P3 - Priority document US 61_3558342024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D105 - Sava et al.2024-09-02Not public
DFMP D25 - Correspondence_Lancet_2011_377_121-1222024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D21 - EMA Assessment Report for Jevtana (cabazitaxel) January 20 20112024-09-02Not public
DFMP D113 - US Code of Federal Regulations Title 21_Chapter I_Part 3142024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP D91 - Bissery et al.2024-09-02Not public
DFMP P6 - Priority document US 61_3839332024-09-02Not public
TW D 2 - Medicines for Europe2024-09-02Not public
DFMP D38 - Sanofi Press Release_September 17 20072024-09-02Not public
DFMP P4 - Priority document US 61_3558882024-09-02Not public
DFMP D13 - Pivot et al.2024-09-02Not public
Acknowledgement-of-lodging2024-09-02Not public
DFMP D1 - Sanofi-Aventis - XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone2024-09-02Not public
DFMP D14 - FDA label for docetaxel (Taxotere) 20072024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D105 - Sava et al.2024-09-02Not public
DFMP P2 - Priority document US 61_2939032024-09-02Not public
DFMP D7 - Beardsley et al.2024-09-02Not public
DFMP D3a - Blog post by Dr. Barry Mirtsching 12 October 20072024-09-02Not public
DFMP P3 - Priority document US 61_3558342024-09-02Not public
DFMP D37 - Winquist et al.2024-09-02Not public
DFMP D110 - Consolidated List of documents EPO2024-09-02Not public
DFMP D13 - Pivot et al.2024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D38 - Sanofi Press Release_September 17 20072024-09-02Not public
TW D 2 - Medicines for Europe2024-09-02Not public
DFMP D9 - Galletti et al.2024-09-02Not public
DFMP D18 - EMA Guideline on the Evaluation of Anticancer Medicinal Products in Man 20062024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D3b - Further blog post by Dr. Mirtsching July 6 20072024-09-02Not public
DFMP P5 - Priority document US 61_3699292024-09-02Not public
DFMP D108 - Barraclough and Davis2024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
2024 09 02 Sanofi vs. Zentiva Statement of Defence and Counterclaim for Revoc2024-09-02Not public
DFMP D113 - US Code of Federal Regulations Title 21_Chapter I_Part 3142024-09-02Not public
DFMP D102 - Tannock_Clin. Oncol. 19892024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP 1 - Confirmation of payment of court fees2024-09-02Not public
DFMP D111 - INN Publication 20082024-09-02Not public
DFMP D4 - Mita et al.2024-09-02Not public
DFMP P1 - Priority document US 61_2561602024-09-02Not public
DFMP D21 - EMA Assessment Report for Jevtana (cabazitaxel) January 20 20112024-09-02Not public
DFMP D29 - Tannock et al.2024-09-02Not public
DFMP D90 - Goetz et al.2024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D109 - Albarqouni2024-09-02Not public
DFMP D10 - Sanofi-Aventis Press Release_ 21 December 20092024-09-02Not public
DFMP D104 - Tannock_Clin. Oncol. 19962024-09-02Not public
DFMP D91 - Bissery et al.2024-09-02Not public
DFMP D2 - National Horizon Scanning Centre2024-09-02Not public
DFMP D26 - Attard et al.2024-09-02Not public
DFMP P6 - Priority document US 61_3839332024-09-02Not public
DFMP D35 - Leaflet Aventis Oncology 20032024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
TW D 3 - Report EU Commission2024-09-02Not public
DFMP D72 - Scher et al.2024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
DFMP D103 - Fossa. et al.2024-09-02Not public
DFMP P4 - Priority document US 61_3558882024-09-02Not public
DFMP D25 - Correspondence_Lancet_2011_377_121-1222024-09-02Not public
DFMP D112 - Excerpt from the online National Cancer Institute_s Drug Dictionary re. cabazitaxel2024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
DFMP D15 - de Bono et al.2024-09-02Not public
DFMP P7 - Priority document US 61_3899692024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
TW D 2 - Medicines for Europe2024-09-02Not public
DFMP D112 - Excerpt from the online National Cancer Institute_s Drug Dictionary re. cabazitaxel2024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D2 - National Horizon Scanning Centre2024-09-02Not public
DFMP D108 - Barraclough and Davis2024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D110 - Consolidated List of documents EPO2024-09-02Not public
DFMP D91 - Bissery et al.2024-09-02Not public
DFMP P1 - Priority document US 61_2561602024-09-02Not public
DFMP P2 - Priority document US 61_2939032024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
DFMP D3a - Blog post by Dr. Barry Mirtsching 12 October 20072024-09-02Not public
DFMP D111 - INN Publication 20082024-09-02Not public
DFMP D37 - Winquist et al.2024-09-02Not public
DFMP 1 - Confirmation of payment of court fees2024-09-02Not public
DFMP D13 - Pivot et al.2024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D14 - FDA label for docetaxel (Taxotere) 20072024-09-02Not public
DFMP D102 - Tannock_Clin. Oncol. 19892024-09-02Not public
DFMP D72 - Scher et al.2024-09-02Not public
DFMP P5 - Priority document US 61_3699292024-09-02Not public
DFMP D103 - Fossa. et al.2024-09-02Not public
TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP D38 - Sanofi Press Release_September 17 20072024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
DFMP D109 - Albarqouni2024-09-02Not public
TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP P3 - Priority document US 61_3558342024-09-02Not public
DFMP D1 - Sanofi-Aventis - XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone2024-09-02Not public
DFMP D104 - Tannock_Clin. Oncol. 19962024-09-02Not public
DFMP D18 - EMA Guideline on the Evaluation of Anticancer Medicinal Products in Man 20062024-09-02Not public
DFMP D113 - US Code of Federal Regulations Title 21_Chapter I_Part 3142024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP P7 - Priority document US 61_3899692024-09-02Not public
DFMP D15 - de Bono et al.2024-09-02Not public
DFMP D29 - Tannock et al.2024-09-02Not public
DFMP D10 - Sanofi-Aventis Press Release_ 21 December 20092024-09-02Not public
DFMP P4 - Priority document US 61_3558882024-09-02Not public
DFMP D25 - Correspondence_Lancet_2011_377_121-1222024-09-02Not public
DFMP P6 - Priority document US 61_3839332024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D9 - Galletti et al.2024-09-02Not public
TW D 3 - Report EU Commission2024-09-02Not public
DFMP D35 - Leaflet Aventis Oncology 20032024-09-02Not public
DFMP D26 - Attard et al.2024-09-02Not public
DFMP D3b - Further blog post by Dr. Mirtsching July 6 20072024-09-02Not public
DFMP D105 - Sava et al.2024-09-02Not public
DFMP D4 - Mita et al.2024-09-02Not public
DFMP D21 - EMA Assessment Report for Jevtana (cabazitaxel) January 20 20112024-09-02Not public
DFMP D90 - Goetz et al.2024-09-02Not public
TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
2024 09 02 Sanofi vs. Zentiva Statement of Defence and Counterclaim for Revoc2024-09-02Not public
DFMP D7 - Beardsley et al.2024-09-02Not public
Acknowledgement-of-lodging2024-09-02Not public
DFMP D110 - Consolidated List of documents EPO2024-09-02Not public
DFMP P4 - Priority document US 61_3558882024-09-02Not public
Exhibit TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP 1 - Confirmation of payment of court fees2024-09-02Not public
DFMP D2 - National Horizon Scanning Centre2024-09-02Not public
DFMP D10 - Sanofi-Aventis Press Release_ 21 December 20092024-09-02Not public
Exhibit TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D7 - Beardsley et al.2024-09-02Not public
DFMP D21 - EMA Assessment Report for Jevtana (cabazitaxel) January 20 20112024-09-02Not public
DFMP D3b - Further blog post by Dr. Mirtsching July 6 20072024-09-02Not public
DFMP D72 - Scher et al.2024-09-02Not public
DFMP D29 - Tannock et al.2024-09-02Not public
DFMP D3a - Blog post by Dr. Barry Mirtsching 12 October 20072024-09-02Not public
DFMP D9 - Galletti et al.2024-09-02Not public
DFMP D1 - Sanofi-Aventis - XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone2024-09-02Not public
DFMP D105 - Sava et al.2024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
DFMP D35 - Leaflet Aventis Oncology 20032024-09-02Not public
Exhibit TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
TW D 5 - FR SMPC Cabazitaxel2024-09-02Not public
DFMP P7 - Priority document US 61_3899692024-09-02Not public
Exhibit TW D 2 - Medicines for Europe2024-09-02Not public
DFMP D109 - Albarqouni2024-09-02Not public
DFMP D104 - Tannock_Clin. Oncol. 19962024-09-02Not public
DFMP P2 - Priority document US 61_2939032024-09-02Not public
DFMP D13 - Pivot et al.2024-09-02Not public
DFMP D113 - US Code of Federal Regulations Title 21_Chapter I_Part 3142024-09-02Not public
TW D 3 - Report EU Commission2024-09-02Not public
DFMP D112 - Excerpt from the online National Cancer Institute_s Drug Dictionary re. cabazitaxel2024-09-02Not public
DFMP D18 - EMA Guideline on the Evaluation of Anticancer Medicinal Products in Man 20062024-09-02Not public
DFMP D25 - Correspondence_Lancet_2011_377_121-1222024-09-02Not public
DFMP D11 - Les Echos_ 22 Dec 20092024-09-02Not public
DFMP D90 - Goetz et al.2024-09-02Not public
DFMP D91 - Bissery et al.2024-09-02Not public
DFMP P5 - Priority document US 61_3699292024-09-02Not public
2024 09 02 Sanofi vs. Zentiva Statement of Defence and Counterclaim for Revoc2024-09-02Not public
DFMP D102 - Tannock_Clin. Oncol. 19892024-09-02Not public
Exhibit TW D 8 - DE Leaflet Cabazitaxel2024-09-02Not public
DFMP D37 - Winquist et al.2024-09-02Not public
DFMP D15 - de Bono et al.2024-09-02Not public
DFMP D38 - Sanofi Press Release_September 17 20072024-09-02Not public
Exhibit TW D 7 - DE SMPC Cabazitaxel2024-09-02Not public
DFMP D111 - INN Publication 20082024-09-02Not public
Exhibit TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP P1 - Priority document US 61_2561602024-09-02Not public
DFMP P3 - Priority document US 61_3558342024-09-02Not public
DFMP P6 - Priority document US 61_3839332024-09-02Not public
DFMP D108 - Barraclough and Davis2024-09-02Not public
DFMP D4 - Mita et al.2024-09-02Not public
DFMP D26 - Attard et al.2024-09-02Not public
DFMP D14 - FDA label for docetaxel (Taxotere) 20072024-09-02Not public
Exhibit TW D 4 - ANSM Cabazitaxel2024-09-02Not public
DFMP D103 - Fossa. et al.2024-09-02Not public
Exhibit TW D 6 - FR Leaflet Cabazitaxel2024-09-02Not public
commentPreliminaryObjection2024-07-14Not public
Exhibit No. E.42024-07-14Not public
Exhibit No. E.32024-07-14Not public
Exhibit No. E.32024-07-14Not public
Exhibit No. E.62024-07-14Not public
Exhibit No. E.1.22024-07-14Not public
Written comments2024-07-14Not public
Exhibit No. E.82024-07-14Not public
Exhibit No. E.52024-07-14Not public
Exhibit No. E.1.12024-07-14Not public
Exhibit No. E.22024-07-14Not public
Exhibit No. E.1.32024-07-14Not public
Exhibit No. E.72024-07-14Not public
preliminaryObjection2024-07-02Not public
240702_Sanofi-vs-Zentiva-Preliminary-Objection2024-07-02Not public
Exhibit_TW-D-12024-07-02Not public
Notification Of Service2024-06-13Not public
Proof of service2024-06-13Not public
Notification Of Service2024-06-11Not public
Proof of service2024-06-11Not public
Notification Of Service2024-06-06Not public
Proof of service2024-06-06Not public
Acknowledgement of access to case2024-06-04Not public
Acknowledgement of access to case2024-06-04Not public
Acknowledgement of access to case2024-06-03Not public
Panel-Appointment2024-06-03Not public
epoUploadDocumentsWorkflow2024-05-23Not public
Document from EPO2024-05-22Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Letter for Service2024-05-21Not public
Panel-Appointment2024-05-16Not public
EPO-Request-for-case-pending2024-05-16Not public
Receipt2024-05-16Not public
Formal-checks_Notification-of-positive-outcome2024-05-16Not public
Exhibit No. D.1.22024-05-14Not public
Exhibit No. B.2.12024-05-14Not public
Exhibit No. 0.12024-05-14Not public
Exhibit No. C.1.22024-05-14Not public
Exhibit No. 0.22024-05-14Not public
Exhibit No. B.1.1.12024-05-14Not public
Exhibit No. D.2.22024-05-14Not public
Exhibit No. D.32024-05-14Not public
Exhibit No. 0.22024-05-14Not public
Exhibit No. C.12024-05-14Not public
Exhibit No. B.2.52024-05-14Not public
Exhibit No. 0.32024-05-14Not public
Exhibit No. 0.12024-05-14Not public
Exhibit No. B.1.1.22024-05-14Not public
Exhibit No. D.3.12024-05-14Not public
Exhibit No. B.12024-05-14Not public
Exhibit No. D.2.12024-05-14Not public
Exhibit No. B.2.42024-05-14Not public
Exhibit No. D.2.32024-05-14Not public
Exhibit No. A.12024-05-14Not public
Exhibit No. B.2.22024-05-14Not public
Exhibit No. A.1.12024-05-14Not public
Exhibit No. B.1.22024-05-14Not public
Exhibit No. D.1.12024-05-14Not public
Exhibit No. B.1.12024-05-14Not public
Exhibit No. 0.32024-05-14Not public
Statement of claim2024-05-14Not public
Statement of claim2024-05-14Not public
Exhibit No. B.2.32024-05-14Not public
Formal-checks_Request-for-correction2024-05-14Not public
Acknowledgement-of-lodging2024-05-13Not public
Exhibit No. C.1.22024-05-13Not public
Exhibit No. 0.22024-05-13Not public
Exhibit No. D.1.22024-05-13Not public
Exhibit No. C.12024-05-13Not public
Exhibit No. A.12024-05-13Not public
Exhibit No. B.1.1.22024-05-13Not public
Exhibit No. D.2.22024-05-13Not public
Exhibit No. 0.22024-05-13Not public
Exhibit No. D.2.12024-05-13Not public
Exhibit No. B.1.1.12024-05-13Not public
Exhibit No. B.1.12024-05-13Not public
Exhibit No. B.2.52024-05-13Not public
Exhibit No. D.3.12024-05-13Not public
Exhibit No. 0.32024-05-13Not public
Exhibit No. D.1.12024-05-13Not public
Exhibit No. B.2.32024-05-13Not public
Exhibit No. 0.32024-05-13Not public
Exhibit No. B.1.22024-05-13Not public
Exhibit No. D.32024-05-13Not public
Exhibit No. B.2.12024-05-13Not public
Exhibit No. D.2.32024-05-13Not public
Exhibit No. B.2.42024-05-13Not public
Exhibit No. 0.12024-05-13Not public
Exhibit No. A.1.12024-05-13Not public
Statement of claim2024-05-13Not public
Exhibit No. 0.12024-05-13Not public
Exhibit No. B.2.22024-05-13Not public
Exhibit No. B.12024-05-13Not public